Bio-Techne
TECH
#1767
Rank
A$14.76 B
Marketcap
$93.40
Share price
-0.89%
Change (1 day)
-12.32%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) Fails to deliver data

Key failure to deliver metrics for Bio-Techne:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Bio-Techne (TECH) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Bio-Techne (TECH) - since 2014

Volume in USD (price x number of shares), data since 2014

Bio-Techne (TECH) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$0.56 M-98.06%
2024A$29 M-32.17%
2023A$42.76 M-15.62%
2022A$50.68 M-42.56%
2021A$88.22 M200.19%
2020A$29.39 M124.27%
2019A$13.1 M90.7%
2018A$6.87 M-5.05%
2017A$7.23 M-54.94%
2016A$16.06 M17.78%
2015A$13.63 M342.13%
2014A$3.08 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$18.45 MA$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.84 MA$14.37 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.83 MA$65.17 M๐Ÿ‡บ๐Ÿ‡ธ USA
A$18.07 MA$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.22 MA$2.22 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$0.28 BA$1.23 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.1 MA$0.14 M๐Ÿ‡บ๐Ÿ‡ธ USA